Juvenile Localized Scleroderma. Questions of Treatment
Вопросы современной педиатрии, 2020 Juvenile localized scleroderma (JLS) is a group of childhood diseases with the main symptom — skin and subcutaneous structures lesions, without any organ involvement. There is active (inflammatory) and fibrotic phase in development of JLS.
Rinat K. Raupov, Mikhail M. Kostik
doaj +7 more sources
Coexistence of Localized and Systemic Juvenile Scleroderma: A Case Report and Review of Literature [PDF]
Clinical Case ReportsJuvenile scleroderma (JS) is a rare chronic connective tissue disorder characterized by progressive fibrosis of the skin and soft tissues with/without internal organ involvements.
Aye Miremarati +4 more
doaj +5 more sources
Juvenile localized scleroderma: A disease with significant morbidity [PDF]
Journal of the European Academy of Dermatology and Venereology, 2023 Localized scleroderma (Syn: Morphoea) is an autoimmune disorder manifesting as sclerosis, atrophy of skin, subcutaneous tissue and may extend into underlying muscle and bone. Although juvenile localized scleroderma is a rare disorder, 20– 30% of patients
Shital Poojary
semanticscholar +4 more sources
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives [PDF]
Pediatric Rheumatology Online Journal, 2023 Background Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permanent damage and worse outcomes.
Leigh A. Stubbs +20 more
doaj +7 more sources
Indian Journal of Dermatology, 2015 Port wine stain and juvenile localized scleroderma are two different dermatoses usually encountered in pediatric age group. Up to now, there are reports of morphea patients initially diagnosed and treated as port wine stain.
Seval Dogruk Kacar +5 more
doaj +3 more sources
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study [PDF]
Pediatric Rheumatology Online Journal, 2019 Background We designed and initiated a pilot comparative effectiveness study for juvenile localized scleroderma (jLS), for which there is limited evidence on best therapy.
Suzanne C. Li +17 more
doaj +3 more sources
Juvenile localized scleroderma: beyond our eyes can see
Residência PediátricaINTRODUÇÃO: Esclerodermia localizada juvenil (ELJ) é a forma mais comum de esclerodermia na infância e representa um grupo de entidades clínicas distintas, com espessamento de epiderme, derme e tecido subcutâneo adjacente.
A. V. C. Almeida +6 more
semanticscholar +3 more sources
Durometry as an outcome measure in juvenile localized scleroderma. [PDF]
Br J Dermatol, 2016 Poff S +4 more
europepmc +5 more sources
Juvenile Localized Scleroderma [PDF]
Definitions, 2020 National Cancer Institute
semanticscholar +3 more sources
Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma. [PDF]
Arthritis Care Res (Hoboken), 2017 ObjectiveLocalized scleroderma can negatively affect children's quality of life (QoL), but predictors of impact have not been well described. We sought to identify predictors of QoL impact in juvenile localized scleroderma patients.MethodsWe analyzed longitudinal data from a single‐center cohort of juvenile localized scleroderma patients, using ...
Ardalan K, Zigler CK, Torok KS.
europepmc +6 more sources